Management of periocular basal and squamous cell carcinoma: A series of 485 cases

被引:84
|
作者
Nemet, Arie Y.
Deckel, Yael
Martin, Peter A.
Kourt, Georgina
Chilov, Michael
Sharma, Vidushi
Benger, Ross
机构
[1] Sydney Hosp, Dept Ophthalmol, Oculoplast Unit, Washington, DC 20010 USA
[2] Sydney Eye Hosp, Sydney, NSW 2001, Australia
关键词
D O I
10.1016/j.ajo.2006.03.055
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To analyze the outcome of management of patients with basal cell carcinomas (BCCs) and squanous cell carcinomas (SCCs) in a tertiary referral eye center in Sydney, Australia. DESIGN: Retrospective case series. METHODS: Review of medical records of 485 consecutive cases (469 patients) with confirmed eyelid cancer. INTERVENTION PROCEDURES: Surgical excision with 3, to 5-mm clinically clear margins and histologic confirmation of the surgical margins. Frozen section histology or Mobs' micrographic surgery (MMS) was used for incompletely excised cases, and those located in the medial canthus or close to the lacrimal drainage system. Standard reconstruction techniques were employed. MAIN OUTCOME MEA, SURES: Survival period free of tumor, incomplete excision, recurrences, type of closure, and complications. RESULTS: Excision was initially incomplete in 25.4% of all tumors. Morpheaform type of BCC (chi(2) p < .001), and medial canthus location BCCs (chi(2) p < .05) were associated with a higher incomplete resection rate. A 35.9% incomplete excision rate was associated with a significantly higher recurrence rate compared with complete excision (8.4% and 4.6%, respectively, chi(2) p < .05). Twenty-seven patients (5.6%) had a recurrent tumor. After incomplete excision, there was no recurrence with MMS, but 4.7% recurrence rate when frozen section technique was used (P < .05). Local postoperative complications occurred in 41 patients (8.5%). CONCLUSIONS: In the setting of a tertiary referral center, incomplete primary resection of an eyelid skin cancer is the main risk factor for recurrence. Incomplete resection is significantly associated with medial canthus location and morpheaform type of BCC and with moderately differentiated SCC. MMS is the safer technique after incomplete tumor excision.
引用
收藏
页码:293 / 297
页数:5
相关论文
共 50 条
  • [1] Targeted Therapy for Orbital and Periocular Basal Cell Carcinoma and Squamous Cell Carcinoma
    Yin, Vivian T.
    Pfeiffer, Margaret L.
    Esmaeli, Bita
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2013, 29 (02): : 87 - 92
  • [2] Periocular basal cell carcinoma: demographic, clinical, histological and immunohistochemical evaluation of a series of 39 cases
    Costea, Claudia Florida
    Turliuc, Mihaela Dana
    Sava, Anca
    Dimitriu, Gabriela
    Dumitrescu, Gabriela Florenta
    Danca, Cristina
    Cucu, Andrei Ionut
    Bogdanici, Camelia Margareta
    Costache, Irina Iuliana
    Buzduga, Catalin Mihai
    Ciocoiu, Manuela
    Tanase, Daniela Maria
    Dragomir, Raluca Alina
    Carauleanu, Alexandru
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2019, 60 (01): : 77 - 86
  • [3] Guidelines for vismodegib in the management of periocular basal cell carcinoma
    Hussain, Ahsen
    Tucker, Nancy
    DeAngelis, Dan D.
    Yin, Vivian T.
    Ing, Edsel
    Arthurs, Bryan
    Gill, Harmeet S.
    Hardy, Isabelle
    Hurwitz, Jeff
    Kratky, Vladimir
    Maleki, Babak
    Nijhawan, Navdeep
    Oestreicher, James
    Zafar, Aftab
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2020, 55 (03): : 245 - 252
  • [4] Systemic acitretin in the management of periocular squamous cell carcinoma
    Wang, Haoyu
    Bata, Bashar
    Currie, Zanna
    Salvi, Sachin
    Tan, Jennifer
    BMJ CASE REPORTS, 2021, 14 (04)
  • [5] Periocular basal cell carcinoma
    Heindl, Ludwig M.
    OPHTHALMOLOGE, 2020, 117 (02): : 93 - 94
  • [6] Role of non-surgical therapies in the management of periocular basal cell carcinoma and squamous intra-epidermal carcinoma: a case series and review of the literature
    Attili, Sasi K.
    Ibbotson, Sally H.
    Fleming, Colin
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2012, 28 (02) : 68 - 79
  • [7] Periocular squamous cell carcinoma
    Limawararut, Vanessa
    Leibovitch, Igal
    Sullivan, Tim
    Selva, Dinesh
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 35 (02): : 174 - 185
  • [8] Periocular squamous cell carcinoma
    Thosani, Maya K.
    Schneck, Gideon
    Jones, Evan C.
    DERMATOLOGIC SURGERY, 2008, 34 (05) : 585 - 599
  • [9] Management of periocular basal cell carcinoma by Mohs micrographic surgery
    Litwin, Andre S.
    Rytina, Ed
    Ha, Thomas
    Rene, Cornelius
    Woodruff, Simon A.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2013, 24 (03) : 232 - 234
  • [10] Vismodegib for periocular basal cell carcinoma: an international multicentre case series
    H. Oliphant
    J. Laybourne
    K. Chan
    A. Haridas
    M. R. Edmunds
    D. Morris
    L. Clarke
    M. Althaus
    P. Norris
    M. Cranstoun
    T. J. Sullivan
    S. N. Rajak
    Eye, 2020, 34 : 2076 - 2081